Goodbody Health (AQSE: GDBY) is pleased to announce a new sponsorship agreement with James Hedley for the Formula GB3 2022 Season. The Company Sponsored James in the 2019 Ginetta Junior Season following his win in the 2018 Ginetta Junior Winter Series Championship. He went on to become the 2019 Ginetta Junior Champion before moving onto Formula 4 in 2020 and 2021.

Sativa Wellness Group is pleased to announce a change of name to Goodbody Health Inc to align the parent company with its main brand name “Goodbody” and its trading subsidiaries “Goodbody Wellness Ltd” and “Goodbody Botanicals Ltd”. After significant feedback, the Board decided that the Goodbody brand using the proposition “Know More-Live Better” better promotes and reflects the Company’s Strategic Direction as a Health and Wellness Company.

The Company today announces certain management share compensation arrangements and amendments that have been approved by the Board of Directors with a view to both incentivising and aligning management and shareholder interests.

Record Week
Sativa Wellness Group announces record week, over 140 clinics and £13.8m revenue.

Sativa Wellness Group is pleased to announce that an application has been made to the Aquis Stock Exchange (“AQSE”) and the Canadian Securities Exchange (“CSE”)

Sativa Wellness Group is pleased to announce today that it has appointed Arden Partners Plc (“Arden”) as the Company’s AQSE Corporate Adviser and Broker.

Sativa Wellness Group Inc. is pleased to announce today that it has partnered with Superdrug Stores Plc (“Superdrug”) to offer an extensive range of blood tests.

Sativa Wellness Group Inc. is pleased to announce today a second quarterly profit in Q3 2021. The Company has filed the Financial Statements and Management’s Discussion and Analysis for Q3 September 2021, demonstrating continued strong growth.

Sativa Wellness Group Inc. is pleased to announce today that Monday this week saw the highest number of tests booked in a day exceeding 850 tests and £100,000 (C$180,000) of revenue. While the majority of tests are still COVID-19 tests for travellers, the proportion of blood tests being booked is growing consistently.